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Iliac vein stenting in postmenopausal leg swelling
Seshadri Raju, MD, Matthew Oglesbee, BS, and Peter Neglén, MD, PhD, Flowood, Miss
Background: Leg swelling in menopausal women is well known. Prevailing concept in primary care is that it is polycentric
and a treatable cause may not be found. Patients are placed on empiric diuretics often without benefit. Our clinical
experience indicates that iliac venous vein obstruction is the core cause; a variety of secondary factors common in
postmenopausal women precipitate symptoms.
Patients and Methods: A total of 163 limbs in 150 postmenopausal women (>55 years of age) with leg swelling
unresponsive to conservative therapy underwent intravascular ultrasound-guided iliac vein stenting over an 11-year
period. Preoperative investigations included duplex, airplethysmography, venous pressure tests, contrast studies, and
lymphangiography. The postmenopausal group constituted 9% of all limbs (n 1760) stented for chronic venous disease
(CVD) during the same period and 18% of those stented for swelling (n  922). Median age was 67 (range, 55-92) and
left-to-right ratio 2:1.
Results: Iliac vein obstruction was “primary” (nonthrombotic) in 65% and postthrombotic in 35% of limbs; 35% of limbs
had obstruction only and 65% combined obstruction/reflux. Lymphatic dysfunction was present in 21% of the limbs.
Mean intravascular ultrasound area stenosis was 68% 22 SD. Mean follow-up was 22 months (26 SD) (range, 1-113
months). Secondary stent patency (6 years) was 100% in primary and 91% in postthrombotic limbs; overall 98%. Swelling
improved significantly (P < .0001) from preoperative grade 2.5 (0.8 SD) to postoperative grade 1.2 (1.2 SD).
Associated pain also improved significantly (P < .0001) from preoperative visual analog scale 3.5 (3 SD) to
postoperative 0.9 (2.1  SD). Quality-of-life (CIVQ) scores improved significantly in every category and overall (P <
.0001).
Conclusions: Patients with postmenopausal leg swelling often have obstructive venous pathology even though suggestive
venous history and other signs are often absent. Morbidity arises from painful swelling that affects mobility, quality of
life, and ability of self-care at later stages of life. Outpatient percutaneous iliac vein stenting affords substantial symptom
relief and improvement in quality-of-life measures. Recognition of the clinical complex as a distinct entity of venous
origin may lead to greater awareness and effective treatment. (J Vasc Surg 2011;53:123-30.)Leg swelling in postmenopausal women is a common
clinical problem. After systemic causes have been excluded,
there is a large segment where a specific cause is not
apparent. Hormonal changes that occur with aging and
menopause appear to have a role, but the precise mecha-
nisms remain ill-defined.1-3 Since prior history or features
of chronic venous disease (CVD) is usually absent, a venous
cause is seldom investigated. Although other menopausal
symptoms may be present,1,4 the leg swelling is a dominant
feature in many patients seeking specific treatment. When
the edema is substantial or when associated with pain,
quality of life (QOL) may be impacted in a significant way
(Figs 1 and 2). In geriatric women, the condition may be
disabling, hindering ability of self-care prompting consid-
erations of assisted living. The condition, although fre-
quently treated in clinical practice, is yet to be defined as a
specific clinical entity. A search of the Pubmed and MeSh
From The Rane Center at the River Oaks Hospital.
Competition of interest: Dr Raju and Dr Neglén hold stock in Veniti, a
medical device company.
Presented at the Twenty-second Annual Meeting of the American Venous
Forum, Amelia Island, Fla, February 2010.
Reprint requests: Seshadri Raju, MD, The Rane Center at the River Oaks
Hospital, 1020 River Oaks Drive, No. 420, Flowood, MS 39232 (e-mail:
rajumd@earthlink.net).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a competition of interest.
0741-5214/$36.00
Copyright © 2011 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2010.07.068databases returns no specific subheading, only links to
related features such as hormones or edema. This article
details our clinical experience with this condition. A venous
basis was found to underlie the leg swelling and venous
stenting may afford relief. Based on the unique clinical
features and possible corrective treatment, it is argued that
the symptom complex be recognized as a specific clinical
entity with venous etiology.
PATIENTS AND METHODS
A total of 163 limbs in 150 postmenopausal women
(55 years age) presenting with leg swelling as the primary
complaint and unresponsive to conservative therapy under-
went intravascular ultrasound (IVUS)-guided iliac vein
stenting over an 11-year period. The age (55) selection to
define the postmenopausal group was based on the average
age of menopause in United States (52 years) per Na-
tional Institutes of Health. Bilateral leg swelling was
present in 20 (13%) patients and bilateral venous stenting
was carried out in 13 (9%) of the patients. The postmeno-
pausal group constituted 9% of all CVD limbs (n  1760)
stented during the same period and 18% (n 922) of those
stented for swelling. Patients with chronic venous disease
or proximate history of deep venous thrombosis (DVT)
(5 years) preceding onset of symptoms were excluded to
refine the subset without other well-known venous causes
of similar symptomatology. Patients with a remote (5
years) history of DVT were, however, included in analysis,
as it is often not considered by primary physicians when
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was 68 (range, 55-92) and left-to-right ratio 2:1.
Investigations. A comprehensive set of laboratory
and radiologic investigations were carried out. This in-
cluded arm/foot pressure differential, ambulatory venous
pressure, air plethysmography, duplex examination, iso-
Fig 1. Painful foot swelling with inability to wear proper
footwear.
Fig 2. Limb swelling in a postmenopausal woman retarding mo-
bility; note compression marks.tope lymphangiography, and transfemoral venographywith exercise femoral pressure measurement. Test details
have been described before.5 Since one or more tests were
not carried out for technical or patient compliance reasons
in individual patients, n values for cited results vary and are
noted in context. IVUS examination of the iliac outflow
was the final arbiter of stenosis; stents were concurrently
placed with prior consent.
Technique. The technique of iliac venous stenting has
been described in detail before.5-10 Briefly, large (14-18
mm diameter) Walstents (Boston Scientific Corporation,
Inc, Natick, Mass) were placed with generous overlap at
stent joins after predilatation to normal vein caliber for the
location. Stents extended from the distal inferior vena cava
to a landing site free of disease below, often the common
femoral vein below the inguinal ligament. Concurrent laser
saphenous vein ablation6 was carried out in 20 limbs (13%),
as saphenous reflux was thought to be contributory but not
the main cause of the leg swelling. Nonocclusive lesions
were stented in 159 limbs (98%), and recanalization of
chronic total occlusions9 was required in four limbs (2%).
Perioperative low-molecular-weight heparin and intra-
operative heparin (100 U/kg) or bivalrudin (50 mg) were
used. Patients were discharged after overnight stay on
long-term aspirin unless specific thrombophilia or extensive
postthrombotic disease was present, in which case warfarin
was used.
Patients were clinically examined at 6 weeks, 3 months,
9months, and then annually. The CIVIQmethod was used
for QOL assessment;11 latest patient response was used for
analysis. Stent patency was established by venography at 3
to 6 months and yearly thereafter. Duplex ultrasound scan-
ning12 has been used in the last few years in addition, for
more frequent stent surveillance than is possible with
venography.
Data analysis. Data were extracted from electronic
medical records that were contemporaneously created dur-
ing clinical evaluation. Continuous and categorical vari-
ables were analyzed by paired (two-tailed) nonparametric
Wilcoxon-rank test and 2 test, respectively. Secondary
patency rates and clinical outcomes were calculated using
cumulative analysis with the Kaplan-Meier method. These
curves were pruned at SEM  10%. A commercially avail-
able statistical program (Graph Pad Prism for Windows
[version 3.0]) was used for analysis. A P value of less than
.05 was considered significant.
RESULTS
Clinical features. All limbs were categorized as class
C3 (CEAP). The mean duration of leg swelling was 25 
40 months before referral. Limb swelling was assessed
preoperatively by physical examination (grade 1, pitting
edema; grade 2, ankle edema; grade 3, gross; involving the
leg or limb) assigning the highest grade of swelling present.
Distribution of swelling grades 1 to 3 in analyzed limbs was
23%, 15%, and 62% respectively. Mean grade of swelling
was 2.5  0.8 SD. Limb pain was assessed by visual ana-
logue scale as described by Scott.13 Associated pain was
see te
al occ
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pain level on visual analog scale (VAS) was 3.5  3.0 SD.
The etiology of iliac vein stenosis was primary in 106
(65%) (Fig 3) and postthrombotic in 57 (35%) limbs (Fig
4). A remote history of previous DVT, (often forgotten)
was elicited in 20 (13%) patients; 5 or more years had
elapsed before onset of current symptoms (Table I). A
Fig 3. Nonthrombotic iliac vein lesion (NIVL) in a pa
distal lesions are present (left and middle). The ven
venography in the diagnosis of iliac vein lesions is poor (
Fig 4. Types of postthrombotic iliac vein lesions that c
secondary insult. Focal stenosis (left); diffuse iliac stenosi
veins (arrows) and the absence of collaterals; chronic tot
Table I. Clinical history
Remote events (n  150 patients)
DVT/phlebitis: 20 (13%)
Trauma/major surgery: 48 (32%)
Cancer/radiation: 13 (9%)
Congestive heart failure: 4 (3%)
Cellulitis: 2 (1%)
Medications (n  150 patients)
Hormone replacement: 46 (31%)
Cardiac/antihypertensive: 91 (61%)
Diuretics: 65 (43%)
Recent events precipitating leg swelling
(n  163 limbs)
Trauma/major surgery: 44 (27%)
Immobility/obesity: 10 (6%)
Cellulitis: 10 (6%)
Cancer/radiation: 2 (1%)
DVT, Deep venous thrombosis.previous history of prothrombotic events (trauma, majorsurgery, cancer, congestive failure, and cellulitis) without a
clear history of DVT was elicited in 45% of patients. Nearly
two-thirds of patients were on cardiovascular medications
known to promote limb swelling and nearly one-third of
patients were receiving hormone replacement therapy.
About half the patients had been placed on empiric diuret-
ics. Symptoms were precipitated by recent trauma/ortho-
pedic surgery in 27% of limbs. New onset of reflux in the
context of a preexisting iliac vein obstruction could have
been a precipitating cause in others. Reflux details are given
below.
Mean IVUS area stenosis (electronic planimetry, post-
stent area minus prestent area as ratio at maximum point of
stenosis) was 68%  22 SD. In 21 limbs, the IVUS calcu-
lated area stenosis was50%. In 9/21 of these limbs, IVUS
area stenosis was 50% but had failed to detect a higher-
grade distal nonthrombotic iliac vein lesion (NIVL) steno-
sis near the hypogastric orifice, which was unmasked by
gentle balloon “sizing” (1 atm inflation).10 In the re-
maining 12 limbs, the poststent area had residual stenosis
from continuing compression of the stent by the lesion10
despite pre- and poststent dilatation. Because of the way
area stenosis was calculated, this resulted in an underesti-
mation of the true stenosis present.When the poststent area
with postmenopausal leg swelling. Both proximal and
was unremarkable (right). Diagnostic sensitivity of
xt).
main silent for years before swelling is precipitated by a
ter); note size discrepancy between the femoral and iliac
lusion (right).tient
ograman re
s (cenwas normalized by substituting luminal area values found in
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limbs.
In 57 limbs (35%), iliac vein obstruction was the only
pathology and there was no associated reflux (Table II). In
the remainder, obstruction was associated with reflux as
follows: superficial reflux only in 51 (31%) limbs, deep
reflux only in 17 (10%) limbs, and combination in 32 (20%)
limbs. The deep reflux was segmental in 42/49 (84%) of
limbs with deep reflux. Perforator reflux was present in
10 limbs (1%). The severity of associated reflux as judged by
several parameters (Table III) was mild. Only 23 limbs had
a multisegment score of 3 and axial reflux was present in
only seven limbs. Values for ambulatory venous pressure
and VFI90 in limbs with reflux were within the range
considered “normal” (Normal values for ambulatory pres-
sure drop 50%, VFT 20 s and VFI90 2 mL/s).
Lymphangiography was normal in 92 (79%) of 114
limbs with available data; abnormalities were present in 22
(21%) limbs: delayed 15 (14%) and absent in 6 (6%) limbs
and enhanced in 1 limb (1%). Preoperative test parameters
suggestive of venous obstruction are detailed in Table IV.
One or more preoperative tests were suggestive of obstruc-
tion in 130 limbs (80%) and were unrevealing in 33 limbs
(20%), although stentable obstructions were found with
IVUS in all during the procedure. Thirty-day mortality was
nil. DVT occurred in three limbs 30 days and in four
Table II. Reflux detail in 163 limbs stented for
obstruction
Type of reflux Limbs Prevalence (%)
No venous reflux 57 35%
Superficial reflux 51 31%
Deep reflux alone 17 10%
Deep  superficial reflux 32 20%
Data missing 6 4%
Table III. Severity of reflux (n  100 limbs)a
Limbs Percent
Reflux multisegment scoreb
 3: 77 77%
 3: 23 23%
Axial reflux 7 7%
Limbs Median  SD
AVP, percent drop 69 70%  18
AVP; VFT, seconds 68 42  31
APG: VFI90, mL/s 84 1.6  1.4
APG, Air plethysmography; AVP, ambulatory venous pressure; VFI90, ve-
nous filling index.VFT, venous refilling time.
aFifty-seven limbs with no reflux and 6 others with missing data were
excluded from the total number of limbs (n  163).
bA score of 1 each is given to reflux in the above-knee great saphenous vein
(GSV), below-the-knee GSV, small saphenous vein, perforators, femoral
vein, profunda femoris, and popliteal vein. The total reflux score for the limb
is calculated (max 7).others later (overall 4%).Stent outcome. Cumulative patency and cumulative
relief of pain and swelling is shown in Figures 5, 6 and 7,
respectively. Secondary stent patency (6 years) was 100% in
primary and 91% in postthrombotic limbs; overall 98%.
Four stents occluded during the observation period and
three were reopened by catheter lysis. There was significant
improvement in swelling after stent correction (poststent
swelling 1.2  1.2 SD, P  .0001) and in pain (poststent
VAS 0.9 2.1 SD, P .0001). QOL (CIVIC) outcome is
shown in Table V. There was significant improvement in all
six categories and in the aggregate score.
DISCUSSION
Currently, when a postmenopausal woman presents
with leg swelling to the primary physician, duplex exami-
nation for DVT is commonly carried out. If negative,
additional investigations necessary to rule out cardiac, re-
nal, autoimmune, and other systemic causes may be carried
out as well. When these causes are ruled out, an amorphous
Table IV. Tests suggestive of venous obstruction in
limbs before stent placement
Positive/tested
limbs
Sensitivity
%
Venography:
Lesions suspecteda 85/124 69%
Collaterals 32/116 28%
Femoral vein pressures:
3 mmHg gradient over
contralateral limb 10/96 10%
4 mmHg increase with exercise 37/111 33%
Arm/foot pressure difference 4
mmHg rest 7/90 8%
Reactive hyperemia 6 mm Hg at
rest 44/90 49%
Duplex: lack of phasicity 54/136 40%
One or more tests suggested obstruction in 80% of limbs; in 20% of limbs,
none of the tests were positive. IVUS confirmed lesions in all 163 limbs.
aInterpretation by authors with bias.
Fig 5. Cumulative stent patency (secondary) curves in postmeno-
pausal leg swelling. Separate curves are shown for primary (NIVL),
postthrombotic etiologies, and overall.polycentric etiology is assigned and the condition is treated
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edema) and compression. As history and other signs sug-
gestive of CVD are usually absent, relevant venous investi-
gations are seldom carried out especially when bilateral leg
Fig 6. Cumulative relief of pain after iliac vein stent placement in
patients with postmenopausal leg swelling. Separate curves are
shown for significant ( 3 VAS) and total relief of pain.
Fig 7. Cumulative relief of swelling after iliac vein stent place-
ment in postmenopausal women. The upper curve shows swelling
improvement as reported by the patient (subjective). The bottom
two curves represent objective assessment by examination: signifi-
cant (1 grade) improvement and for complete relief of swelling.
Table V. Quality of life (CIVIQ) before and after stent
placement in postmenopausal leg swelling (n  65
patientsb)
CIVIQ categories Prestent score Poststent score P value
Pain 4 (1-5) 3 (1-5) .0007a
Work 4 (1-5) 3 (1-5) .0004a
Sleep 4 (1-5) 2 (1-5) .0044a
Social 4 (1-5) 3 (1-5) .0055a
Morale 3 (1-5) 3 (1-5) .002a
Total 71 (20-100) 50 (20-96) .0001a
aSignificant.
bData available with both prestent and poststent questionnaires.swelling is present. When accompanied by other meno-pausal symptoms such as for example “hot flashes”, hor-
monal supplements may be prescribed.1,4 Amelioration of
edema with hormonal supplements has been variable. It
seems unlikely that this approach will be useful except in the
mildest forms of leg swelling. Many patients in this age
group are on cardiac and antihypertensive medications,
some of which are known to promote leg swelling. Swit-
chover to alternates without this side effect when feasible
(frequently not) may occasionally be rewarding. As out-
lined in this article, an underlying significant iliac vein
obstruction is present in those presenting with highly
symptomatic postmenopausal leg swelling. Significant bi-
lateral lesions are present in about 20% of patients with iliac
vein obstruction.5,14 Compression when properly applied
can be effective but fails for a variety of reasons.15
In a fraction of the patients, a remote history of throm-
bosis years or decades ago may be elicited on specific
questioning. In others, a prothrombotic event such as
severe trauma, fracture and immobilization, past use of
birth control pills, major surgery, or illness can be elicited.
A fraction of all DVT, perhaps about 30%, is estimated to be
silent. Also likely, some thromboses, particularly of the iliac
vein were simply missed. Examination of the iliac vein is not
routine in many laboratories. The incidence of DVT in-
creases with age.16,17 Based on estimated annual inci-
dence, 15% to 20% of postmenopausal women are likely to
harbor postthrombotic limbs. The iliac vein pathology was
postthrombotic in one-third of the cases and was primary
(NIVL) in the other two-thirds in this analysis. These are
clearly long-standing lesions that predated the onset of leg
swelling. A previously silent lesion had become symptom-
atic for some reason. We hypothesize that iliac vein lesions
are permissive, remaining silent until additional insult to
the limb precipitates symptoms.18 Many human disease
conditions are precipitated by onset of secondary pathology
in the context of preexisting silent permissive primary pa-
thology. Some examples include patent foramen ovale/
parodoxic embolus, obesity/diabetes, cardiac defects/en-
docarditis, ureteric reflux/pyelonephritis, hypertension/
stroke, and lung cavitation/aspergilloma. Typically, the
prevalence of the permissive lesion in the diseased subset is
several times higher than in the general population.19-21
Significant (50%) NIVL type of lesions in silent form
are estimated to be present in about 25% of the general
population22,23 but are found in 90% of symptomatic
patients.18 This report suggests that post-thrombotic
iliac vein lesions in addition to NIVLs, can remain silent
and function as permissive lesions until secondary pa-
thology precipitates symptoms. Recurrent DVT is a ma-
jor instigator of postthrombotic syndrome, which im-
plies a similar concept.24
Women are prone to numerous other events in the
menopausal years that are productive of symptoms in the
context of a preexisting permissive iliac vein pathology (Fig
8). These include antihypertensive and cardiac medications
that promote fluid retention,25 joint surgery, saphenous
vein harvest for coronary or other bypass, arthritis that
retards mobility and calf pump function, a sedentary habit
symp
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orthostasis (TV leg), postmenopausal hormonal changes,
and onset of reflux, incidence of which increases with age26
and has a higher prevalence in women. The secondary
insult may not be productive of leg swelling in the absence
of venous pathology. For example, saphenous reflux, in and
of itself seldom produces grade 3 limb swelling, although
lesser-grade swelling may be seen. Similar comments apply
to nonaxial segmental reflux when the reflux score is low
(2) or when ambulatory venous pressure or airplethys-
mography (VFI90) do not indicate severe global reflux as
was the case in this case material. Onset of cellulitis can
further destabilize fluid homeostasis and produce lym-
phatic damage. Secondary lymphatic dysfunction is a fea-
ture of venous disease.27,28 Iliac vein stenting alone has
been shown to be effective in symptom relief in many of
these instances even when the specific secondary pathology
(recurrent cellulitis, secondary lymphedema, and reflux
even if severe) is not directly addressed.29-31
A general observation in managing disease with com-
plex permissive/secondary pathologies is that correction of
the permissive pathology alone is often sufficient to ame-
liorate symptoms and the need for specific correction of
secondary pathology is lessened. For example, weight re-
duction alone may control secondary diabetes; elimination
of acid reflux often remits night time asthma and so on. The
results of stenting to correct the underlying iliac vein ste-
nosis may be viewed in this fashion.
Patients reported swelling improvement in 67% of
limbs. This could be confirmed by objective examination in
50% (cumulative) of the limbs where swelling had im-
proved by 1 grade with complete absence of swelling
noted in 33% of the stented limbs at 5 years. The discrep-
ancymay be due to placebo effect or swelling is perceived to
be less because it is less painful. However, the swelling
assessment methodology itself understates clinical relief.
For example, swelling of the entire limb may recede below
Fig 8. Trauma to the limb (left), infection (celluliti
replacement, right) can precipitate leg swelling in the c
Postmenopausal women are subject to numerous other s
to render a previously silent iliac vein obstructive lesionthe knee; and massive leg swelling that has visibly improvedby 50% or more will show no grade change (grade 3) after
stent placement in either instance although affording easier
mobility. Similarly, massive foot swelling may improve
enough (still grade 2) to allow shoe wear. The grading
system used herein predates the VCSS32 system and was
retained because the latter is entirely subjective. Limb
swelling is perhaps the most recalcitrant among CVDman-
ifestations and relatively difficult to eradicate completely
because fluid homeostasis even in normal individuals is so
precarious.33-36 Identifying and correcting stent malfunc-
tions in patients with symptomatic residual/recurrent
swelling may improve outcome.10 Preexisting reflux does
not worsen after stent placement.5
Residual swelling is better tolerated if the associated
pain is relieved. A percentage (78%) (cumulative) of limbs
in this series had substantial pain relief with total relief in
65% at 5 years after the stent procedure.
Clinical outcome is probably better reflected in QOL
measures, which showed significant improvement in every
category. QOL methodology used in this study is free of
author bias in assessment, as it depends solely on patient
responses.
Underlying venous pathology in postmenopausal leg
swelling is not different from that in other subsets, but
hormonal influences probably play a secondary precipitat-
ing role. These patients tend not to be appropriately inves-
tigated because of presentation of swelling sans other ve-
nous signs. The belief that “fluid retention” is characteristic
of this stage in life is pervasive. Venous investigations
should be pursued in postmenopausal leg swelling unre-
sponsive to conservative measures. Traditional venous in-
vestigations, such as routine duplex or venography (Fig 3)
are unsatisfactory for assessment of iliac vein pathology.29
Venographic collaterals are infrequently present. Other
signs pointing to the presence of an obstructive lesion are
often subtle and easily missed on routine interpretations.
Nearly one-third of the lesions were impervious to even
ter), or orthopedic joint replacement (bilateral knee
t of a preexisting permissive iliac vein lesion (see text).
dary factors including onset of reflux that may aggravate
tomatic with onset of leg swelling.s, cen
ontex
econsensitized observers as in this report. Diagnostic yield may
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IV), but this is unlikely to be adopted in routine practice. In
contrast, IVUS has a very high diagnostic yield18,37 and is
recommended even if traditional investigations are nega-
tive. IVUS is conveniently combined with iliac vein stent-
ing (with prior consent), as it is essential to successful stent
placement. About 10% of significant lesions are impervious
even to IVUS, and routine “balloon sizing” of the entire
iliac-femoral segment is recommended to unmask hidden
lesions.10 The degree of stenosis suitable for stenting re-
mains unsettled. The idea of “critical” stenosis is derived
from the arterial system where a stenotic lesion produces a
flow reduction in the context of arteriolar resistance. In the
venous system, a tandem distal functional stenosis repre-
sented by resistance arterioles does not exist and the aim is
to reduce pressure at the venular end of the capillary to
improve fluid homeostasis. In practice, we have found
correction of 50% IVUS area stenosis to yield clinical
relief.5
Stenting of IVUS-identified lesions is minimally inva-
sive, safe, has excellent long-term patency, and affords
substantial symptom relief and improved QOL in patients
with postmenopausal leg swelling.
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